Clinical trial
A Non-interventional Study to Estimate the Rates of Outcomes in ACS Patients in Moscow
NCT03654157 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Non-interventional Study to Estimate the Rates of Outcomes in ACS Patients in Moscow
- Lead sponsor
- AstraZeneca
- Phase
- Observational
- Overall status
- Completed
- Start date
- March 25, 2018
- Completion date
- October 19, 2021
- Enrollment
- 1,576 (actual)
- Sites
- 27
Conditions
As the registry lists them; a condition with its own page is linked.
cardiovascular death, heart attack, stroke